🟢 Pharming Group is trading 11% up today after third-quarter revenue topped expectations

Pharming Group is trading at €0.94, up 10.91%, after preliminary third-quarter revenue beat market expectations.

• Its October 22 preliminary report showed revenue of approximately US$117.6 million, up 21% year over year, supported by stronger RUCONEST and Joenja performance.
• Pharming Group narrowed 2026 revenue guidance to US$380–390 million and lowered operating-expense guidance; the full report was brought forward to October 27.
• The supplied price context gives no volume data.